Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

229 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies.
Ellis C, Luger T, Abeck D, Allen R, Graham-Brown RA, De Prost Y, Eichenfield LF, Ferrandiz C, Giannetti A, Hanifin J, Koo JY, Leung D, Lynde C, Ring J, Ruiz-Maldonado R, Saurat JH; ICCAD II Faculty. Ellis C, et al. Among authors: de prost y. Br J Dermatol. 2003 May;148 Suppl 63:3-10. doi: 10.1046/j.1365-2133.148.s63.1.x. Br J Dermatol. 2003. PMID: 12694268 Free article. Review. No abstract available.
Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug.
Kapp A, Papp K, Bingham A, Fölster-Holst R, Ortonne JP, Potter PC, Gulliver W, Paul C, Molloy S, Barbier N, Thurston M, de Prost Y; Flare Reduction in Eczema with Elidel (infants) multicenter investigator study group. Kapp A, et al. Among authors: de prost y. J Allergy Clin Immunol. 2002 Aug;110(2):277-84. doi: 10.1067/mai.2002.126500. J Allergy Clin Immunol. 2002. PMID: 12170269 Clinical Trial.
Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
Wahn U, Bos JD, Goodfield M, Caputo R, Papp K, Manjra A, Dobozy A, Paul C, Molloy S, Hultsch T, Graeber M, Cherill R, de Prost Y; Flare Reduction in Eczema with Elidel (Children) Multicenter Investigator Study Group. Wahn U, et al. Among authors: de prost y. Pediatrics. 2002 Jul;110(1 Pt 1):e2. doi: 10.1542/peds.110.1.e2. Pediatrics. 2002. PMID: 12093983 Clinical Trial.
Consensus statement on the safety profile of topical calcineurin inhibitors.
Bieber T, Cork M, Ellis C, Girolomoni G, Groves R, Langley R, Luger T, Meurer M, Murrell D, Orlow S, Paller A, de Prost Y, Puig L, Ring J, Saurat JH, Schwarz T, Shear N, Stingl G, Taieb A, Thestrup-Pedersen K; Pediatric Advisory Committee of the Food and Drug Administration. Bieber T, et al. Among authors: de prost y. Dermatology. 2005;211(2):77-8. doi: 10.1159/000086431. Dermatology. 2005. PMID: 16088148 No abstract available.
229 results